iTeos Therapeutics, Inc. (ITOS) announced on Monday the appointment of David Feltquate as chief medical officer.
Feltquate is expected to manage the company's clinical development and regulatory strategies.
He has almost 20 years of experience in immuno-oncology clinical development, translational medicine, and the advancement of diagnostic assays. Before joining iTeos, Feltquate was the chief medical officer at Palleon Pharmaceuticals and held leadership roles at Novartis and Bristol Myers Squibb.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.